Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

CORALEX MEDICAL : revenue, balance sheet and financial ratios

CORALEX MEDICAL is a French company founded 6 years ago, specialized in the sector Gestion de fonds. Based in COUTERNON (21560), this company of category PME shows in 2021 a net income positive of 2 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-18

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - CORALEX MEDICAL (SIREN 879304194)
Indicator 2021 2020
Revenue N/C N/C
Net income 2 256 € -653 €
EBITDA -5 311 € -240 €
Net margin N/C N/C

Revenue and income statement

In 2021, CORALEX MEDICAL generates positive net income of 2 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

EBITDA (2021) ?
Gross Operating Surplus (EBITDA)
Definition
Resources generated by current operations, before depreciation and financial expenses.
Formula
Value added - Personnel expenses - Taxes
Interpretation
Positive = profitable activity

-5 311 €

EBIT (2021) ?
EBIT (Operating Income)
Definition
Operating income, including depreciation and provisions.
Formula
EBITDA - Depreciation and provisions + Reversals

-5 926 €

Net income (2021) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

2 256 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 1999%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 95%. This high autonomy means the company finances most of its assets through equity, a sign of strength. Debt repayment capacity (= Financial debt / Cash flow) indicates it would take 19.9 years of cash flow to repay all financial debt. Beyond 7 years, banks generally consider credit risk as high.

Debt ratio (2021) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

1999.452%

Financial autonomy (2021) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

94.863%

Repayment capacity (2021) ?
Repayment capacity
Definition
Number of years needed to repay debts with cash flow.
Formula
Financial debt / Cash flow
Interpretation
< 3 years : Excellent
3-5 years : Fair
> 5 years : Warning

19.854

Solvency indicators evolution
CORALEX MEDICAL

Sector positioning

Debt ratio
1999.45 2021
2020
2021
Q1: 0.02
Med: 16.89
Q3: 133.03
Average

In 2021, the debt ratio of CORALEX MEDICAL (1999.45) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
94.86% 2021
2020
2021
Q1: 13.27%
Med: 52.52%
Q3: 87.72%
Excellent

In 2021, the financial autonomy of CORALEX MEDICAL (94.9%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Repayment capacity
19.85 years 2021
2020
2021
Q1: -0.13 years
Med: 0.0 years
Q3: 3.51 years
Average +50 pts over 2 years

In 2021, the repayment capacity of CORALEX MEDICAL (19.85) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 58.48. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2021) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

58.475

Interest coverage (2021) ?
Interest coverage
Definition
Ability to cover interest charges with operating income.
Formula
EBIT / Interest expenses
Interpretation
> 3 : Comfortable
1.5-3 : Acceptable
< 1.5 : Risk

-15.402

Liquidity indicators evolution
CORALEX MEDICAL

Sector positioning

Liquidity ratio
58.48 2021
2020
2021
Q1: 95.51
Med: 362.13
Q3: 2062.09
Average -29 pts over 2 years

In 2021, the liquidity ratio of CORALEX MEDICAL (58.48) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.

Interest coverage
-15.4x 2021
2020
2021
Q1: -41.55x
Med: 0.0x
Q3: 0.0x
Average +16 pts over 2 years

In 2021, the interest coverage of CORALEX MEDICAL (-15.4x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments. Average customer payment term: 0 days (formula: Customer receivables / Revenue incl. VAT x 360). Supplier term: 14 days. Favorable situation: supplier credit is longer than customer credit by 14 days.

Operating WCR (2021) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2021) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2021) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

14 j

Inventory turnover (2021) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
CORALEX MEDICAL

Positioning of CORALEX MEDICAL in its sector

Comparison with sector Gestion de fonds

Valuation estimate

Based on 76 transactions of similar company sales in 2021, the value of CORALEX MEDICAL is estimated at 24 666 € (range 5 874€ - 30 974€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2021
76 tx
5k€ 24k€ 30k€
24 666 € Range: 5 874€ - 30 974€
NAF 5 année 2021

Valuation method used

Net Income Multiple
2 256 € × 10.9x = 24 666 €
Range: 5 874€ - 30 974€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 76 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Gestion de fonds)

Compare CORALEX MEDICAL with other companies in the same sector:

Frequently asked questions about CORALEX MEDICAL

What is the revenue of CORALEX MEDICAL ?

The revenue of CORALEX MEDICAL is not publicly disclosed (confidential accounts filed with INPI).

Is CORALEX MEDICAL profitable?

Yes, CORALEX MEDICAL generated a net profit of 2 k€ in 2021.

Where is the headquarters of CORALEX MEDICAL ?

The headquarters of CORALEX MEDICAL is located in COUTERNON (21560), in the department Cote-d'Or.

Where to find the tax return of CORALEX MEDICAL ?

The tax return of CORALEX MEDICAL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does CORALEX MEDICAL operate?

CORALEX MEDICAL operates in the sector Gestion de fonds (NAF code 66.30Z). See the 'Sector positioning' section above to compare the company with its competitors.